Skip to main content
Back to RA Capital Management

RA Capital Management's Biotechnology Portfolio

Browse 82 Biotechnology companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
82
Total Funding in Biotechnology
$8.8B

Biotechnology Portfolio Companies (82)

Export
BiotechnologyHealth CareMedicalTherapeutics

Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.

Dallas, United States
May 2026
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cambridge, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnology

cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.

San Diego, United States
May 2026
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.

Durham, United States
April 2026
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedicalWellness

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

Cambridge, United States
April 2026
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Dublin, Ireland
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalNeurosciencePharmaceutical

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

Redmond, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Foster City, United States
April 2026
$48.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Wilmington, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

Biotechnology

Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.

San Francisco, United States
April 2026
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Copenhagen, Denmark
April 2026
$135.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Charlestown, United States
March 2026
$240.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

Cambridge, United States
March 2026
$40.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.

Cambridge, United States
March 2026
$50.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyClinical TrialsTherapeutics

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

Sioux Falls, United States
March 2026
$85.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife Science

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

La Jolla, United States
March 2026
$35.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalPharmaceutical

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Copenhagen, Denmark
October 2025
$157.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalMedical DeviceTherapeutics

VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.

Boulder, United States
October 2025
$17.3M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyOncology

Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).

Marseille, France
October 2025
$122.4M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical

Indapta Therapeutics is a privately held biotechnology company.

San Francisco, United States
October 2025
$50.8M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

Emeryville, United States
October 2025
$45.2M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Portland, United States
September 2025
$95.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscience

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Boston, United States
September 2025
$25.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.

London, United Kingdom
September 2025
$32.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsLife Science

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

New York, United States
August 2025
$44.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Boston, United States
April 2025
$59.2M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

Cambridge, United States
April 2025
$9.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

San Mateo, United States
March 2025
$35.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Bambusa Therapeutics operates as biotechnology company.

Boston, United States
February 2025
$90.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalProduct Research

AmbAgon Therapeutics is a developer of cancer molecule therapeutics.

San Francisco, United States
February 2025
$5.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscience

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

South San Francisco, United States
November 2024
$101.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.

Boston, United States
September 2024
$120.0M
Series A

Founder Contacts

19,000+ verified contacts

Alternative MedicineBiotechnologyTherapeutics

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Boston, United States
August 2024
$112.3M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalTherapeutics

Halda Therapeutics is a research-stage drug discovery company.

New Haven, United States
August 2024
$126.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceOncologyProduct Research

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

Cambridge, United States
August 2024
$120.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Carmel, United States
August 2024
$63.5M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Seattle, United States
August 2024
$144.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Allschwil, Switzerland
June 2024
$90.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

Philadelphia, United States
June 2024
$51.4M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedical

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

Cambridge, United States
May 2024
$95.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

San Mateo, United States
May 2024
$182.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyTherapeutics

Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.

San Francisco, United States
April 2024
$55.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

Charlestown, United States
April 2024
$48.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyOncologyTherapeutics

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Seattle, United States
February 2024
$112.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

La Jolla, United States
October 2023
$85.0M
Series A

Founder Contacts

19,000+ verified contacts

BioinformaticsBiometricsBiopharmaBiotechnologyOncology

Mariana Oncology is a biotechnology research industry.

Watertown, United States
September 2023
$175.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife Science

ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.

San Francisco, United States
August 2023
$4.0M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedical

Capacity Bio is a therapeutics company that is focused on mitophagy.

Palo Alto, United States
March 2023
$35.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.

San Diego, United States
January 2023
$6.9M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedicalTherapeutics

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Watertown, United States
January 2026
$125.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalPrecision Medicine

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Cambridge, United States
January 2026
$305.0M
Series F

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Lexington, United States
December 2025
$120.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsManufacturing

Nature’s Toolbox is a biotechnology company that provides a proprietary host-independent biological manufacturing and development platform.

Rio Rancho, United States
December 2025
$10.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyInformation TechnologyMedicalProduct Research

Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.

Berkeley, United States
November 2025
$65.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth DiagnosticsTherapeutics

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

Waltham, United States
November 2025
$3.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical Device

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

Cambridge, United Kingdom
November 2025
$115.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyProduct ResearchTherapeutics

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

San Diego, United States
March 2026
$505.0M
Undisclosed

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedical

Zura Bio is a clinical-stage, multi-asset biotechnology company.

Henderson, United States
February 2026
$125.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceOncologyTherapeutics

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Cambridge, United States
February 2026
$150.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalTherapeutics

Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.

Raleigh, United States
February 2026
$130.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

New York, United States
February 2026
$400.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife Science

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Palo Alto, United States
February 2026
$125.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Redwood City, United States
February 2026
$50.1M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncologyTherapeutics

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Waltham, United States
February 2026
$40.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Westlake Village, United States
February 2026
$130.0M
Series D

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

San Carlos, United States
January 2026
$632.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.

San Carlos, United States
January 2026
$1.6M
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.

Shanghai, China
January 2026
$287.0M
Series D

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Richmond, United States
January 2026
$115.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Philadelphia, United States
January 2026
$135.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Biotechnology

EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries.

Copenhagen, Denmark
December 2025
$7.1M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalTherapeutics

Ambros Therapeutics is a clinical-stage biotechnology company.

Irvine, United States
December 2025
$125.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

San Francisco, United States
December 2025
$60.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Boston, United States
December 2025
$350.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Cambridge, United States
December 2025
$402.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Belite Bio is a clinical stage biopharmaceutical drug development company.

San Diego, United States
December 2025
$350.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Waltham, United States
November 2025
$125.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyPersonal Health

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

South San Francisco, United States
November 2025
$75.0M
Corporate Round

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsNeurosciencePharmaceutical

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

New Haven, United States
November 2025
$200.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.

Cambridge, United States
October 2025
$3.6M
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Cambridge, United States
October 2025
$197.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.

San Francisco, United States
October 2025
$183.0M
Series C

Founder Contacts

19,000+ verified contacts

Explore RA Capital Management's Full Portfolio

View all companies funded by RA Capital Management across every industry and funding stage.

View Full RA Capital Management Portfolio